European equity markets edged higher on Friday, buoyed by a sharp rebound in Novo Nordisk A/S shares that offset a slide in the automotive sector. The Danish drugmaker surged after analysts upgraded its earnings outlook, lifting the broader pharma index for investors and analysts in Europe.

Stellantis shares fell 2.5% after a weaker-than-expected quarterly report, sparking concerns about European auto demand. The decline weighed on the automotive index, but the pharma rally helped keep the Euro Stoxx 50 within a narrow range for market participants and analysts today and tomorrow as.

Investors now focus on how the Novo Nordisk upside will influence the broader healthcare sector and whether the automotive slump signals a broader slowdown. Analysts warn that earnings season could amplify volatility, especially in sectors tied to consumer spending in Europe and global markets for.

Next week, market watchers will track the European Central Bank policy meeting and upcoming earnings from other auto giants. A positive outlook from Novo Nordisk could lift sentiment, while any further weakness in the automotive sector may test the resilience of the Euro Stoxx 50.